Literature DB >> 21181176

Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010.

Christoph Gensch1, Uta Hoppe, Michael Böhm, Ulrich Laufs.   

Abstract

This article gives an overview on the late-breaking clinical trials in the field of cardiovascular medicine which were presented during the hotline sessions at the American Heart Association Congress, held in Chicago, USA, from 13 to 17th November 2010. The data have been presented by leading experts in the field with relevant positions in the trials. The summaries provided in the manuscript were generated from the oral presentations and the webcasts of the American Heart Association (Laufs in Clin Res Cardiol 97:1-11, 2008; Möllmann in Clin Res Cardiol 98:1-7, 2009). The following papers are discussed in alphabetical order: ACT, ADVANCE, ASCEND-HF, ASCOT-CRP, CLOSURE I, DEFINE, EMPHASIS-HF, GRAVITAS, P-OM3, RAFT, ROCKET-AF, SMART-AV, SYMPLICITY HTN-2, TELE-HF, TIM-HF.

Entities:  

Mesh:

Year:  2010        PMID: 21181176     DOI: 10.1007/s00392-010-0270-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  18 in total

1.  Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Authors:  Anthony S L Tang; George A Wells; Mario Talajic; Malcolm O Arnold; Robert Sheldon; Stuart Connolly; Stefan H Hohnloser; Graham Nichol; David H Birnie; John L Sapp; Raymond Yee; Jeffrey S Healey; Jean L Rouleau
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

2.  Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.

Authors:  Kenneth A Ellenbogen; Michael R Gold; Timothy E Meyer; Ignacio Fernndez Lozano; Suneet Mittal; Alan D Waggoner; Bernd Lemke; Jagmeet P Singh; Francis G Spinale; Jennifer E Van Eyk; Jeffrey Whitehill; Stanislav Weiner; Maninder Bedi; Joshua Rapkin; Kenneth M Stein
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

3.  Clinical trial updates and hotline sessions presented at the Scientific Session 2007 of the American Heart Association.

Authors:  U Laufs; H Nef; H Möllmann; F Custodis; M Böhm
Journal:  Clin Res Cardiol       Date:  2007-12-18       Impact factor: 5.460

4.  Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association.

Authors:  Helge Möllmann; Holger Nef; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2008-12-12       Impact factor: 5.460

5.  Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  Stroke       Date:  2010-11-04       Impact factor: 7.914

6.  Telemonitoring in patients with heart failure.

Authors:  Sarwat I Chaudhry; Jennifer A Mattera; Jeptha P Curtis; John A Spertus; Jeph Herrin; Zhenqiu Lin; Christopher O Phillips; Beth V Hodshon; Lawton S Cooper; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2010-11-16       Impact factor: 91.245

Review 7.  [HDL and CETP in atherogenesis].

Authors:  J Pöss; M Böhm; U Laufs
Journal:  Dtsch Med Wochenschr       Date:  2010-01-15       Impact factor: 0.628

8.  Hypertension treatment and control in five European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; Holly Kramer; José R Banegas; Simona Giampaoli; Michel R Joffres; Neil Poulter; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

9.  Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

Authors:  Matthew J Price; Peter B Berger; Dominick J Angiolillo; Paul S Teirstein; Jean-François Tanguay; David E Kandzari; Christopher P Cannon; Eric J Topol
Journal:  Am Heart J       Date:  2009-05       Impact factor: 4.749

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  8 in total

1.  Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011.

Authors:  K Walenta; J M Sinning; N Werner; M Böhm
Journal:  Clin Res Cardiol       Date:  2011-04-23       Impact factor: 5.460

2.  Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.

Authors:  Kun Xing; Xianghua Fu; Yanbo Wang; Wei Li; Xinshun Gu; Guozhen Hao; Qing Miao; Shiqiang Li; Yunfa Jiang; Weize Fan; Wei Geng
Journal:  Heart Vessels       Date:  2015-01-31       Impact factor: 2.037

Review 3.  Update on the management of atrial fibrillation: anticoagulation and medical therapy.

Authors:  Shueh Hao Lim; Hugh Calkins; Sunil K Sinha
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

4.  Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.

Authors:  Adam P Pleister; Ragavendra R Baliga; Garrie J Haas
Journal:  Curr Heart Fail Rep       Date:  2011-09

5.  Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches.

Authors:  Katerina Koniari; John Parissis; Ioannis Paraskevaidis; Maria Anastasiou-Nana
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

6.  New developments in the surgical management of end-stage heart failure.

Authors:  Scott Silvestry
Journal:  Mo Med       Date:  2012 Jul-Aug

7.  Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.

Authors:  Qianxing Zhou; Florian Bea; Michael Preusch; Hongjie Wang; Berend Isermann; Khurrum Shahzad; Hugo A Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2011-06-07       Impact factor: 4.711

8.  Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.

Authors:  F D R Hobbs; A K Roalfe; G Y H Lip; K Fletcher; D A Fitzmaurice; J Mant
Journal:  BMJ       Date:  2011-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.